Reports On Company: Glenmark Pharma
| Glenmark Pharmaceuticals Ltd: Edelweiss Research Report | |
| Company: | Glenmark Pharma |
| Brokerage: | Edelweiss |
| Date of report: | December 7, 2020 |
| Type of Report: | Result Update |
| Recommendation: | Buy |
| Upside Potential: | 11% |
| Summary: | API external sales were strong. As customers look to diversify away from China, expects the API business to continue to post strong growth |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | |